Documents

Federal rules and notices from the public comment record, analyzed continuously.

FDAOther

Revising ANDA Labeling Following Revision of the RLD Labeling

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Submitting Continuous Glucose Monitoring Data in Clinical Trials Guidance for Industry

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Submitting Next-Generation Sequencing Data to the Division of Antivirals; Guidance for Industry

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

FY 2018 Medical Device User Fee Small Business Qualification and Certification; Guidance for Industry, Food and Drug Administration Staff and Foreign Governments

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs; Guidance for Industry; Draft Guidance

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Oct 3
FDAOther

Formal Meetings Between FDA and Sponsors or Requestors of Over-the-Counter Monograph Drugs; Guidance for Industry; Final Guidance

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Effectiveness of Anthelmintics: Specific Recommendations for Caprines; VICH GL14; Guidance for Industry; Final Guidance; #97

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Effectiveness of Anthelmintics: Specific Recommendations for Porcines; VICH GL16; Guidance for Industry; Final Guidance; #110

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Effectiveness of Anthelmintics: Specific Recommendations for Canines; VICH GL19; Guidance for Industry; Final Guidance; #111

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Effectiveness of Anthelmintics: General Recommendations; VICH GL7; Guidance for Industry; Final Guidance; #90

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Effectiveness of Anthelmintics: Specific Recommendations for Chickens Gallus gallus; VICH GL21; Guidance for Industry; Final Guidance; #114

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Effectiveness of Anthelmintics: Specific Recommendations for Ovines; VICH GL13; Guidance for Industry; Final Guidance; #96

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →